Back to search

Institutes outside Greece

An in vitro model for the investigation of mitochondrial dynamics and quality control in Parkinson’s disease using human pluripotent stem cell-derived midbrain dopamine neurons

Abstract

dc:description

Parkinson’s disease (PD) is a common neurodegenerative disorder characterised by severe motor and cognitive disabilities, caused by a profound loss of the midbrain dopaminergic neurons (mDANs). Although symptomatic treatment provides short-term relief, an absolute cure for PD is lacking, mainly because the aetiology of the disorder remains essentially elusive. Pathogenesis of PD has been associated with ageing, environmental and genetic factors: a common denominator being mitochondrial malfunction. Indeed, the identification of specific gene mutations associated with familial early onset PD is improving our understanding of the molecular mechanisms underlying this disease. Several of these genes mediate mitochondrial dynamics (fusion, fission, transport, mitophagy), and there is accumulating evidence that mitochondrial dysfunction is a key player in PD pathogenesis. In this respect, induced pluripotent stem cell (iPSC) technology represents an essential tool as it allows the in vitro modelling of the disease by obtaining human mDANs generated from reprogrammed adult cells derived from PD patients (e.g. dermal fibroblasts). However, insufficient quality, quantity and regional specification of the generated neurons, as well as highly heterogenic cultures could comprise the experimental outcomes, especially when investigating the sensitive to multiple factors mitochondria. This PhD aims to provide a complete in vitro model to image and monitor mitochondrial dynamics and mitochondrial quality control in mDANs that are vulnerable to PD. Following an introductory review on how mitochondrial dysfunction is related to PD, and a description of the general methods used in this study, the first result Chapter describes how combined approaches and techniques from the literature and previous in housegenerated neural differentiation methods led to the production of a suitable for mitochondrial investigation mDAN differentiation protocol. The second result Chapter presents how this protocol was further optimised to generate ~70% mDANs after 35 days of differentiation. The last result Chapter illustrates how the PSC-derived mDANs can be used to investigate mitochondrial dynamics and quality control using a variety of cell- and culture-based assessments. To conclude, this thesis presents an amenable, reproducible and expandable monolayer PSC-derived mDAN differentiation system specifically designed for the in vitro investigation of mitochondrial dynamics and quality control in PD.

Degree

thesis:*
Grantor dc:publisher
Institutes outside Greece
Year dc:date
2017

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Stathakos, Petros
  • Σταθάκος, Πέτρος

Subjects

dc:subject × 22

Rights

Language dc:language
eng

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/61292

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Stathakos, Petros; Σταθάκος, Πέτρος. An in vitro model for the investigation of mitochondrial dynamics and quality control in Parkinson’s disease using human pluripotent stem cell-derived midbrain dopamine neurons. Institutes outside Greece, 2017. http://hdl.handle.net/10442/hedi/61292